Alicja Skrobucha

Hepatic Steatosis in Pulsed Field Ablation for Atrial Fibrillation: Prevalence, Liver Marker Concordance and Acute Procedural Characteristics

Background/Objectives: Hepatic steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD) are cardiometabolic phenotypes relevant to atrial fibrillation (AF), but their prevalence and acute procedural relevance in pulsed field ablation (PFA) are poorly defined...

Emotional distress in patients before first-time and redo catheter ablation for atrial fibrillation

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is frequently accompanied by anxiety and depressive symptoms, which may affect quality of life. While catheter ablation (CA) is an established therapy for AF, data comparing emotional distress burden pri...